Silverback Therapeutics, Inc. logo

Silverback Therapeutics, Inc.

7 Marks
Corp.
First Filed:Mar 24, 2016Latest Filed:May 4, 2021Address:500 Fairview Avenue North, Suite 600, Seattle, WA 98109

Portfolio Overview

Registered
4(57%)
Dead
3(43%)

Top Classes

Class 42
Software, IT Services & Scientific Research
5(71%)
Class 5
Pharmaceuticals
2(29%)

TTAB Proceedings

Total Proceedings
1
As Plaintiff
0(0%)
As Defendant
1(100%)

Top Firms

Carr & Ferrell LLP(May 2021)
7

Trademark Portfolio

7 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
V
V
Service Mark
Stylized
ABANDONED
Owner:
Serial:90689273
Filed:May 4, 2021
Classes:42
SEEKING VICTORY FOR PATIENTS
ABANDONED
Owner:
Serial:90654860
Filed:Apr 19, 2021
Classes:42
IMMUNOTAC
IMMUNOTAC
Trademark
Word
REGISTERED
Owner:
Serial:88108634
Filed:Sep 7, 2018
Classes:5
Registration:6200968
Registered:Nov 17, 2020
Goods & Services
Systemically delivered, locally active immune modulatory conjugates in the nature of pharmaceuticals, including biopharmaceuticals, pharmaceutical preparations, including biopharmaceutical preparations, agents, namely, biopharmaceutical and pharmaceutical preparations and substances, and medicines for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases; pharmaceuticals and pharmaceutical preparations of systemically delivered, locally active immune modulatory conjugates for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases; engineered immunomodulatory therapeutics in the nature of pharmaceuticals, including biopharmaceuticals, pharmaceutical preparations, including biopharmaceutical preparations, agents, namely, biopharmaceutical and pharmaceutical preparations and substances, and medicines for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases
IMMUNOTAC
IMMUNOTAC
Service Mark
Word
REGISTERED
Owner:
Serial:88108651
Filed:Sep 7, 2018
Classes:42
Registration:6707689
Registered:Apr 19, 2022
Goods & Services
Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune modulatory conjugates; pharmaceutical product development of systemically delivered, locally active immune modulatory conjugates
SBT IMMUNOTAC
SBT IMMUNOTAC
Trademark
Word
ABANDONED
Owner:
Serial:87730856
Filed:Dec 21, 2017
Classes:5
SILVERBACK
SILVERBACK
Service Mark
Word
REGISTERED
Owner:
Serial:86952331
Filed:Mar 24, 2016
Classes:42
Registration:6185396
Registered:Oct 27, 2020
Goods & Services
pharmaceutical and therapeutics research and development services; research and development in the therapeutics, pharmaceutical and biotechnology fields; research and product development in the field of human therapeutics; providing a website featuring research and development information in the therapeutics, pharmaceutical and biotechnology fields
SILVERBACK THERAPEUTICS
SILVERBACK THERAPEUTICS
Service Mark
Word
REGISTERED
Owner:
Serial:86952339
Filed:Mar 24, 2016
Classes:42
Registration:6185397
Registered:Oct 27, 2020
Goods & Services
Class 042: pharmaceutical and therapeutics research and development services; research and development in the therapeutics, pharmaceutical and biotechnology fields; research and product development in the field of human therapeutics; providing a website featuring research and development information in the therapeutics, pharmaceutical and biotechnology fields

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.